Cargando…
An Open-Label Prospective Study to Compare the Efficacy and Safety of Topical Fluticasone Versus Tacrolimus in the Proactive Treatment of Atopic Dermatitis
BACKGROUND: Atopic dermatitis (AD), a chronic, recurrent inflammatory skin condition primarily affects children. Topical treatment, systemic treatment, and phototherapy are mainstays of treatment. Topical corticosteroids (TCS) are first-line therapy for AD but are associated with various adverse eff...
Autores principales: | Mudaliyar, Vinodhini R., Pathak, Asha, Dixit, Alok, Kumar, Sweta S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588157/ https://www.ncbi.nlm.nih.gov/pubmed/33150035 http://dx.doi.org/10.5826/dpc.1004a94 |
Ejemplares similares
-
Topical tacrolimus as treatment of atopic dermatitis
por: Furue, Masutaka, et al.
Publicado: (2009) -
A Randomized, Open-Label, Multicenter Trial of Topical Tacrolimus for the Treatment of Pruritis in Patients with Atopic Dermatitis
por: Takeuchi, Satoshi, et al.
Publicado: (2012) -
Topical Tacrolimus for the Treatment of Atopic Dermatitis with Truncal Lesion
por: Ko, Hyun Chang, et al.
Publicado: (2018) -
From the Cochrane Library: Topical Tacrolimus for Atopic Dermatitis
por: Hamp, Austin, et al.
Publicado: (2021) -
Tacrolimus ointment in the management of atopic dermatitis
por: Baldo, Antonello, et al.
Publicado: (2009)